blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2517698

EP2517698 - AGENT FOR TREATING PARKINSON'S DISEASE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  19.01.2018
Database last updated on 13.07.2024
FormerThe patent has been granted
Status updated on  10.02.2017
FormerGrant of patent is intended
Status updated on  20.11.2016
Most recent event   Tooltip10.07.2020Lapse of the patent in a contracting state
New state(s): AL
published on 12.08.2020  [2020/33]
Applicant(s)For all designated states
Obschestvo S Ogranichennoy Otvetstvennostyu "Tomskaya Farmatsevticheskaya Fabrika" (OOO "TFF")
Ul. Elizarovykh 79/4
Tomsk 634021 / RU
[2017/11]
Former [2012/44]For all designated states
Obschestvo S Ogranichennoy Otvetstvennostyu "Tomskaya Farmatsevtichekaya Fabrika" (OOO "TFF")
Ul. Elizarovykh 79/4
Tomsk 634021 / RU
Inventor(s)01 / TOLSTIKOVA, Tatiana Genrihovna
ul. Voevodskogo, 8
Novosibirsk, 630090 / RU
02 / SALAHUTDINOV, Nariman Faridovich
Vesennii proezd, 4-57
Novosibirsk, 630090 / RU
03 / MOROZOVA, Ekaterina Aleksandrovna
ul. Viasemskaya, 2-124
Novosibirsk, 630117 / RU
04 / ARDASHOV, Oleg Vasil'evich
ul. Pirogova, 20/2-712
Novosibirsk, 630090 / RU
05 / IL'INA, Irina Viktorovna
ul. Sibirskaya, 31a-29
Novosibirsk, 630004 / RU
06 / PAVLOVA, Anastasia Viktorovna
ul. Pirogova, 34-31
Novosibirsk, 630090 / RU
07 / VOLCHO, Konstantin Petrovich
Bul'var Molodezhi, 28a-27
Novosibirsk, 630055 / RU
 [2012/44]
Representative(s)Glawe, Delfs, Moll
Partnerschaft mbB von
Patent- und Rechtsanwälten
Postfach 13 03 91
20103 Hamburg / DE
[N/P]
Former [2017/11]Glawe, Delfs, Moll
Partnerschaft mbB
von Patent- und Rechtsanwälten
Postfach 13 03 91
20103 Hamburg / DE
Former [2012/44]Glawe, Delfs, Moll
Patent- und Rechtsanwälte
Rothenbaumchaussee 58
20148 Hamburg / DE
Application number, filing date10844832.523.12.2010
[2017/11]
WO2010RU00778
Priority number, dateRU2009014837624.12.2009         Original published format: RU 2009148376
[2012/44]
Filing languageRU
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2011093742
Date:04.08.2011
Language:RU
[2011/31]
Type: A2 Application without search report 
No.:EP2517698
Date:31.10.2012
Language:EN
[2012/44]
Type: B1 Patent specification 
No.:EP2517698
Date:15.03.2017
Language:EN
[2017/11]
Search report(s)International search report - published on:RU29.09.2011
(Supplementary) European search report - dispatched on:EP05.07.2013
ClassificationIPC:A61K31/015, A61K31/047, A61K31/215, A61P25/16
[2012/44]
CPC:
A61K31/015 (EP,US); C07C35/18 (US); A61K31/047 (EP,US);
A61K31/215 (EP,US); A61P25/16 (EP); C07C69/96 (US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2012/44]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:WIRKSTOFF ZUR BEHANDLUNG VON MORBUS PARKINSON[2012/44]
English:AGENT FOR TREATING PARKINSON'S DISEASE[2012/44]
French:AGENT POUR TRAITER LA MALADIE DE PARKINSON[2012/44]
Entry into regional phase20.07.2012Translation filed 
20.07.2012National basic fee paid 
20.07.2012Search fee paid 
20.07.2012Designation fee(s) paid 
20.07.2012Examination fee paid 
Examination procedure20.07.2012Examination requested  [2012/44]
10.01.2014Amendment by applicant (claims and/or description)
21.09.2015Despatch of a communication from the examining division (Time limit: M04)
08.12.2015Reply to a communication from the examining division
09.03.2016Despatch of a communication from the examining division (Time limit: M04)
27.06.2016Reply to a communication from the examining division
21.11.2016Communication of intention to grant the patent
01.02.2017Fee for grant paid
01.02.2017Fee for publishing/printing paid
01.02.2017Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  21.09.2015
Opposition(s)18.12.2017No opposition filed within time limit [2018/08]
Fees paidRenewal fee
17.10.2012Renewal fee patent year 03
18.12.2013Renewal fee patent year 04
22.12.2014Renewal fee patent year 05
21.12.2015Renewal fee patent year 06
22.12.2016Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU23.12.2010
AL15.03.2017
AT15.03.2017
CY15.03.2017
CZ15.03.2017
DK15.03.2017
EE15.03.2017
ES15.03.2017
FI15.03.2017
HR15.03.2017
IT15.03.2017
LT15.03.2017
LV15.03.2017
MC15.03.2017
MK15.03.2017
NL15.03.2017
PL15.03.2017
RO15.03.2017
RS15.03.2017
SE15.03.2017
SI15.03.2017
SK15.03.2017
SM15.03.2017
TR15.03.2017
BG15.06.2017
NO15.06.2017
GR16.06.2017
IS15.07.2017
PT17.07.2017
[2020/33]
Former [2020/15]HU23.12.2010
AT15.03.2017
CY15.03.2017
CZ15.03.2017
DK15.03.2017
EE15.03.2017
ES15.03.2017
FI15.03.2017
HR15.03.2017
IT15.03.2017
LT15.03.2017
LV15.03.2017
MC15.03.2017
MK15.03.2017
NL15.03.2017
PL15.03.2017
RO15.03.2017
RS15.03.2017
SE15.03.2017
SI15.03.2017
SK15.03.2017
SM15.03.2017
TR15.03.2017
BG15.06.2017
NO15.06.2017
GR16.06.2017
IS15.07.2017
PT17.07.2017
Former [2019/52]HU23.12.2010
AT15.03.2017
CY15.03.2017
CZ15.03.2017
DK15.03.2017
EE15.03.2017
ES15.03.2017
FI15.03.2017
HR15.03.2017
IT15.03.2017
LT15.03.2017
LV15.03.2017
MC15.03.2017
MK15.03.2017
NL15.03.2017
PL15.03.2017
RO15.03.2017
RS15.03.2017
SE15.03.2017
SI15.03.2017
SK15.03.2017
SM15.03.2017
BG15.06.2017
NO15.06.2017
GR16.06.2017
IS15.07.2017
PT17.07.2017
Former [2019/46]HU23.12.2010
AT15.03.2017
CY15.03.2017
CZ15.03.2017
DK15.03.2017
EE15.03.2017
ES15.03.2017
FI15.03.2017
HR15.03.2017
IT15.03.2017
LT15.03.2017
LV15.03.2017
MC15.03.2017
NL15.03.2017
PL15.03.2017
RO15.03.2017
RS15.03.2017
SE15.03.2017
SI15.03.2017
SK15.03.2017
SM15.03.2017
BG15.06.2017
NO15.06.2017
GR16.06.2017
IS15.07.2017
PT17.07.2017
Former [2019/31]HU23.12.2010
AT15.03.2017
CZ15.03.2017
DK15.03.2017
EE15.03.2017
ES15.03.2017
FI15.03.2017
HR15.03.2017
IT15.03.2017
LT15.03.2017
LV15.03.2017
MC15.03.2017
NL15.03.2017
PL15.03.2017
RO15.03.2017
RS15.03.2017
SE15.03.2017
SI15.03.2017
SK15.03.2017
SM15.03.2017
BG15.06.2017
NO15.06.2017
GR16.06.2017
IS15.07.2017
PT17.07.2017
Former [2019/30]AT15.03.2017
CZ15.03.2017
DK15.03.2017
EE15.03.2017
ES15.03.2017
FI15.03.2017
HR15.03.2017
IT15.03.2017
LT15.03.2017
LV15.03.2017
MC15.03.2017
NL15.03.2017
PL15.03.2017
RO15.03.2017
RS15.03.2017
SE15.03.2017
SI15.03.2017
SK15.03.2017
SM15.03.2017
BG15.06.2017
NO15.06.2017
GR16.06.2017
IS15.07.2017
PT17.07.2017
Former [2018/14]AT15.03.2017
CZ15.03.2017
DK15.03.2017
EE15.03.2017
ES15.03.2017
FI15.03.2017
HR15.03.2017
IT15.03.2017
LT15.03.2017
LV15.03.2017
NL15.03.2017
PL15.03.2017
RO15.03.2017
RS15.03.2017
SE15.03.2017
SI15.03.2017
SK15.03.2017
SM15.03.2017
BG15.06.2017
NO15.06.2017
GR16.06.2017
IS15.07.2017
PT17.07.2017
Former [2018/09]AT15.03.2017
CZ15.03.2017
DK15.03.2017
EE15.03.2017
ES15.03.2017
FI15.03.2017
HR15.03.2017
IT15.03.2017
LT15.03.2017
LV15.03.2017
NL15.03.2017
PL15.03.2017
RO15.03.2017
RS15.03.2017
SE15.03.2017
SK15.03.2017
SM15.03.2017
BG15.06.2017
NO15.06.2017
GR16.06.2017
IS15.07.2017
PT17.07.2017
Former [2017/51]AT15.03.2017
CZ15.03.2017
EE15.03.2017
ES15.03.2017
FI15.03.2017
HR15.03.2017
IT15.03.2017
LT15.03.2017
LV15.03.2017
NL15.03.2017
PL15.03.2017
RO15.03.2017
RS15.03.2017
SE15.03.2017
SK15.03.2017
SM15.03.2017
BG15.06.2017
NO15.06.2017
GR16.06.2017
IS15.07.2017
PT17.07.2017
Former [2017/50]AT15.03.2017
CZ15.03.2017
EE15.03.2017
ES15.03.2017
FI15.03.2017
HR15.03.2017
IT15.03.2017
LT15.03.2017
LV15.03.2017
NL15.03.2017
PL15.03.2017
RO15.03.2017
RS15.03.2017
SE15.03.2017
SK15.03.2017
BG15.06.2017
NO15.06.2017
GR16.06.2017
IS15.07.2017
Former [2017/49]AT15.03.2017
CZ15.03.2017
EE15.03.2017
ES15.03.2017
FI15.03.2017
HR15.03.2017
IT15.03.2017
LT15.03.2017
LV15.03.2017
NL15.03.2017
RO15.03.2017
RS15.03.2017
SE15.03.2017
SK15.03.2017
BG15.06.2017
NO15.06.2017
GR16.06.2017
IS15.07.2017
Former [2017/48]CZ15.03.2017
FI15.03.2017
HR15.03.2017
LT15.03.2017
LV15.03.2017
NL15.03.2017
RS15.03.2017
SE15.03.2017
BG15.06.2017
NO15.06.2017
GR16.06.2017
Former [2017/41]FI15.03.2017
HR15.03.2017
LT15.03.2017
LV15.03.2017
NL15.03.2017
RS15.03.2017
SE15.03.2017
BG15.06.2017
NO15.06.2017
GR16.06.2017
Documents cited:Search[A]  - NAPOLITANO A ET AL, "New directions in Parkinson's research and treatment", EXPERT OPINION ON THERAPEUTIC PATENTS, INFORMA HEALTHCARE, GB, (19980101), vol. 8, doi:10.1517/13543776.8.10.1251, ISSN 1354-3776, pages 1251 - 1268, XP002531575 [A] 1-8 * page 1251, line 7 - line 11 * * page 1252, column left * * page 1253, paragraph 3 - page 1254 *

DOI:   http://dx.doi.org/10.1517/13543776.8.10.1251
International search[Y]RU2355390  (NOVOSIB I ORCH KHIM IM N N VOR [RU], et al);
 [Y]  - "Rukovodstvo po meditsine.", DIAGNOSTIKA I TERPIYA, M., ''MIR'', (1997), vol. 1, pages 1018 - 1023, XP008163481
by applicant   - VENGEROVSKY A.I., "Pharmacology lectures for doctors and pharmacists", TOMSK: STT, vol. 198, pages 181 - 186
    - "Pharmacotherapy of parkinsonism and other movement disorders", AMINOFF M.D., Basic and clinical pharmacology, KATSUNG B.G, (2007), vol. 1, pages 539 - 555
    - IL'INA I.V.; VOLCHO K.P.; KORCHAGINA D.V.; BARKHASH V.A.; SALAKHUTDINOV N.F., HELV. CHIM. ACTA, (2007), vol. 90, no. 2, pages 353 - 368
    - RATNER V.V.; ISAEVA Z.G.; POVODIREVA I.P.; GORYACHKINA N.F.; EFREMOV Y.A.; ARBUZOV B.A., "Oxidation of 2-carene by thallium acetate (III", BULLETIN OF THE ACADEMY OF SCIENCE OF THE USSR. CHEMISTRY, (1983), no. 8, pages 1824 - 1828
    - KAWASAKI T.; AGO Y.; KITAO T.; NASHIDA T.; TAKAGI A.; TAKUMA K.; MATSUDA T., "A neuroprotective agent, T-817MA (1-13-[2-(1-benzothiophen-5-yl) ethoxy]propyl} azetidin-3-ol maleate), prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in mice", NEUROPHARMACOLOGY, (2008), vol. 55, doi:doi:10.1016/j.neuropharm.2008.05.032, pages 654 - 660, XP025398892

DOI:   http://dx.doi.org/10.1016/j.neuropharm.2008.05.032
    - DINGEMANSE J., "Catechol-O-methyltransferase Inhibitors: Clinical Potential in the Treatment of Parkinson's Disease", DRUG DEVELOPMENT RESEARCH, (1997), vol. 42, pages 1 - 25
    - QUIK M.; BORDIA T.; O'LEAR,Y K., "Nicotinic receptors as CNS targets for Parkinson's disease", BIOCHEMICAL PHARMACOLOGY, (2007), vol. 74, doi:doi:10.1016/j.bcp.2007.06.015, pages 1224 - 1234, XP022259824

DOI:   http://dx.doi.org/10.1016/j.bcp.2007.06.015
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.